Clinical Trial Update: Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, and efficacy of the PfSPZ-LARC2 malaria vaccine against controlled human malaria infection in malaria-naïve adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• PfSPZ-LARC2 vaccine (PfSPZ-LARC2)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria Falciparum | Phase 1 | Status: RECRUITING